| Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants (NCT04027387) | TaiMed Biologics Inc. | 2019-12-14 |
| The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants (NCT04424264) | Professor Francois Venter | 2019-12-05 |
| Reducing Antiretroviral Treatments (NCT04051970) | ANRS, Emerging Infectious Diseases | 2019-11-27 |
| ART First-line Treatment Durability in Russia (NCT04253119) | MSD Pharmaceuticals LLC | 2019-11-26 |
| Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV (NCT04143594) | Gilead Sciences | 2019-11-22 |
| Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine (NCT03961438) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-11-15 |
| Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women (NCT03837015) | McMaster University | 2019-11-04 |
| A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation (NCT04138199) | AbbVie | 2019-11-01 |
| A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women (NCT04094870) | University of North Carolina, Chapel Hill | 2019-10-30 |
| Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD (NCT04050449) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-10-28 |
| Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE (NCT03998176) | University of Nebraska | 2019-10-09 |
| Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) (NCT04003103) | Merck Sharp & Dohme LLC | 2019-09-19 |
| Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) (NCT03549689) | Philip Grant | 2019-08-01 |
| Self-testing for HCV Re-infection in MSM (NCT04004299) | Erasmus Medical Center | 2019-07-18 |
| Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF) (NCT04009057) | Gilead Sciences | 2019-07-09 |
| Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy (NCT04040075) | Southampton Healthcare, Inc. | 2019-07-01 |
| Pyridostigmine as Immunomodulator in People Living With HIV (NCT03312244) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2019-07-01 |
| Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters (NCT03960645) | Gilead Sciences | 2019-06-28 |
| Quality of Life of Taiwan People Living With HIV (NCT04063306) | Taiwan AIDS Nurse Society | 2019-06-20 |
| Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM (NCT03927313) | University of Cape Town | 2019-06-12 |
| Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection (NCT03913195) | TaiMed Biologics Inc. | 2019-05-30 |
| Pharmacokinetics and Safety of SAR441236 (NCT03705169) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-20 |
| Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa (NCT04066036) | Massachusetts General Hospital | 2019-05-14 |
| Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients (NCT04002323) | University Hospital Virgen de las Nieves | 2019-05-07 |
| Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (NCT03837756) | University of Aarhus | 2019-05-06 |
| Latent HIV-1, Viral Suppress and Hope for HIV Cure (NCT04938518) | Kenya Medical Research Institute | 2019-05-01 |
| B/F/TAF Switch Study for HIV-HBV Coinfection (NCT03797014) | University of Maryland, Baltimore | 2019-04-30 |
| Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002) (NCT03859739) | Merck Sharp & Dohme LLC | 2019-04-26 |
| Prospective Observational Cohort HIV & STI Study in Europe (NCT03866759) | Hendrik Streeck | 2019-04-24 |
| Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults (NCT03844386) | University of North Carolina, Chapel Hill | 2019-04-22 |
| 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults (NCT03875209) | David Ho | 2019-04-08 |
| Clinical Epidemiology Cohort Study for Patient Living With HIV (NCT04061889) | Kaohsiung Veterans General Hospital. | 2019-04-01 |
| Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens (NCT03816137) | Imperial College London | 2019-03-19 |
| An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection (NCT02972450) | ANRS, Emerging Infectious Diseases | 2019-02-20 |
| High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial (NCT05306704) | University of the Punjab | 2019-02-15 |
| Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons (NCT03803605) | University of North Carolina, Chapel Hill | 2019-02-12 |
| IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment (NCT03416790) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2019-02-06 |
| Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study (NCT05634265) | University of Washington | 2019-01-31 |
| Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults (NCT04173819) | International AIDS Vaccine Initiative | 2019-01-25 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects (NCT03706911) | Viriom | 2019-01-21 |
| A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma (NCT03593187) | Assistance Publique - Hôpitaux de Paris | 2019-01-15 |
| HIV, Immune Activation and Salt Sensitive Hypertension (NCT04459741) | Mulungushi University | 2019-01-02 |
| Effect of Dolutegravir Intensification on HIV-1 Reservoirs (NCT05351684) | University of Liege | 2019-01-01 |
| Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (NCT03719664) | Frontier Biotechnologies Inc. | 2018-12-17 |
| Metformin and Systemic Inflammation in HIV (NCT03774108) | Hospital Civil de Guadalajara | 2018-12-15 |
| The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients (NCT03743376) | United BioPharma | 2018-12-12 |
| EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS (NCT03683524) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2018-11-19 |
| Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs (NCT03709355) | Viriom | 2018-11-14 |
| Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (NCT03580668) | Gilead Sciences | 2018-11-13 |
| Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N (NCT05349838) | NEAT ID Foundation | 2018-11-05 |
| PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) (NCT03729752) | University of California, San Francisco | 2018-11-01 |
| B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults (NCT03532425) | University of Alberta | 2018-10-29 |
| Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection (NCT03512210) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2018-10-22 |
| MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002) (NCT03552536) | Merck Sharp & Dohme LLC | 2018-10-07 |
| Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs (NCT03706898) | Viriom | 2018-10-01 |
| Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients (NCT03536234) | Immune System Regulation AB | 2018-09-19 |
| Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants (NCT03631732) | Gilead Sciences | 2018-08-28 |
| Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations (NCT03512795) | Centre Hospitalier Universitaire Dijon | 2018-08-08 |
| Darunavir and Rilpivirine Interactions With Levonorgestrel Implant (NCT03589027) | Makerere University | 2018-08-07 |
| Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen (NCT03646370) | Thomas Jefferson University | 2018-07-25 |
| Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine (NCT03567304) | Chiang Mai University | 2018-07-06 |
| PRO 140 in Treatment-Experienced HIV-1 Subjects (NCT03902522) | CytoDyn, Inc. | 2018-06-25 |
| Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects (NCT03706924) | Viriom | 2018-06-01 |
| Kenya HIV Self-Testing in PrEP Delivery (NCT03593629) | University of Washington | 2018-05-28 |
| Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI). (NCT04225325) | ADRIANO LAZZARIN, MD | 2018-05-07 |
| Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (NCT03333083) | Judit Pich | 2018-05-03 |
| Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (NCT03311945) | Judit Pich | 2018-05-02 |
| LRAs United as a Novel Anti-HIV Strategy. (NCT03525730) | Erasmus Medical Center | 2018-04-18 |
| Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients (NCT03360682) | Fundacion Clinic per a la Recerca Biomédica | 2018-04-13 |
| Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV (NCT03329560) | The University of Texas Health Science Center, Houston | 2018-04-12 |
| Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus (NCT03472326) | Gilead Sciences | 2018-04-03 |
| Pharmacokinetics Distribution of Raltegravir by PET/MR (NCT03174977) | University of California, San Francisco | 2018-04-01 |
| Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant (NCT03118661) | Washington University School of Medicine | 2018-03-19 |
| Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART (NCT03706950) | Viriom | 2018-03-15 |
| Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years (NCT03405935) | Gilead Sciences | 2018-03-01 |
| Improving Pregnancy Outcomes With Progesterone (NCT03297216) | University of North Carolina, Chapel Hill | 2018-02-07 |
| The Medicines Optimisation Review Toolkit Evaluation in HIV Outpatients (NCT03340077) | Brighton and Sussex University Hospitals NHS Trust | 2018-02-06 |
| Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy (NCT03549312) | Saskatchewan Health Authority - Regina Area | 2018-02-01 |
| Dolutegravir in Pregnant HIV Mothers and Their Neonates (NCT03249181) | University of Liverpool | 2018-01-22 |
| The Role of Home Packs of HIV PEPSE in High Risk Individuals (NCT04965662) | Guy's and St Thomas' NHS Foundation Trust | 2018-01-01 |
| Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease. (NCT04098315) | Castagna Antonella | 2017-12-14 |
| A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings (NCT03234400) | International Partnership for Microbicides, Inc. | 2017-12-04 |
| Gut Microbiota and Immune Recovery (NCT03478540) | Shanghai Public Health Clinical Center | 2017-12-01 |
| ANCHORS Study: UH2 Project (NCT03360422) | University of Florida | 2017-12-01 |
| Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011) (NCT03272347) | Merck Sharp & Dohme LLC | 2017-11-27 |
| Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV (NCT03226873) | Montefiore Medical Center | 2017-11-16 |
| Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept. (NCT03539224) | Instituto de Investigación Hospital Universitario La Paz | 2017-11-02 |
| Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH) (NCT03074786) | International Partnership for Microbicides, Inc. | 2017-11-01 |
| A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers (NCT03199690) | St. Stephens Clinical Research | 2017-10-01 |
| Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women (NCT03227731) | University of KwaZulu | 2017-09-28 |
| Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002) (NCT03188523) | Merck Sharp & Dohme LLC | 2017-09-08 |
| An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study (NCT05271370) | CytoDyn, Inc. | 2017-08-29 |
| Providing Unique Support for Health (PUSH) Study (NCT03194477) | Johns Hopkins Bloomberg School of Public Health | 2017-08-01 |
| Specimen Repository for HIV Immunopathogenesis (NCT03579381) | AIDS Healthcare Foundation | 2017-07-31 |
| Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) (NCT03212989) | University of North Carolina, Chapel Hill | 2017-06-27 |
| Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed (NCT03110380) | Gilead Sciences | 2017-06-12 |
| Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients (NCT04596488) | Peking Union Medical College Hospital | 2017-06-01 |
| INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV (NCT03101592) | University of California, Los Angeles | 2017-05-31 |
| Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances (NCT03164135) | Affiliated Hospital to Academy of Military Medical Sciences | 2017-05-30 |
| Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) (NCT03160105) | Calmy Alexandra | 2017-05-19 |